Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,362 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Aberrant protein expression of Appl1, Sortilin and Syndecan-1 during the biological progression of prostate cancer.
Martini C, Logan JM, Sorvina A, Gordon C, Beck AR, S-Y Ung B, Caruso MC, Moore C, Hocking A, Johnson IRD, Li KL, Karageorgos L, Hopkins AM, Esterman AJ, Huzzell C, Brooks RD, Lazniewska J, Hickey SM, Bader C, Parkinson-Lawrence E, Weigert R, Sorich MJ, Tewari P, Martin C, O'Toole S, Bates M, Ward M, Mohammed B, Keegan H, Watson W, Prendergast S, Heffernan S, NiMhaolcatha S, O'Connor R, Malone V, Carter M, Ryan K, Brady N, Clarke A, Sokol F, Prabhakaran S, Stahl J, Klebe S, Samaratunga H, Delahunt B, Selemidis S, Moretti KL, Butler LM, O'Leary JJ, Brooks DA. Martini C, et al. Among authors: moore c. Pathology. 2023 Feb;55(1):40-51. doi: 10.1016/j.pathol.2022.08.001. Epub 2022 Aug 20. Pathology. 2023. PMID: 36089417 Free article.
Prediction of Prostate Cancer Biochemical and Clinical Recurrence Is Improved by IHC-Assisted Grading Using Appl1, Sortilin and Syndecan-1.
Logan JM, Hopkins AM, Martini C, Sorvina A, Tewari P, Prabhakaran S, Huzzell C, Johnson IRD, Hickey SM, Ung BS, Lazniewska J, Brooks RD, Moore CR, Caruso MC, Karageorgos L, Martin CM, O'Toole S, Bogue Edgerton L, Ward MP, Bates M, Selemidis S, Esterman A, Heffernan S, Keegan H, Ní Mhaolcatha S, O'Connor R, Malone V, Carter M, Ryan K, Clarke A, Brady N, Klebe S, Samaratunga H, Delahunt B, Sorich MJ, Moretti K, Butler LM, O'Leary JJ, Brooks DA. Logan JM, et al. Among authors: moore cr. Cancers (Basel). 2023 Jun 16;15(12):3215. doi: 10.3390/cancers15123215. Cancers (Basel). 2023. PMID: 37370825 Free PMC article.
Appl1, Sortilin and Syndecan-1 immunohistochemistry on intraductal carcinoma of the prostate provides evidence of retrograde spread.
Sorvina A, Martini C, Prabhakaran S, Logan JM, S-Y Ung B, Moore C, Johnson IRD, Lazniewska J, Tewari P, Malone V, Brooks RD, Hickey SM, Caruso MC, Klebe S, Karageorgos L, O'Leary JJ, Delahunt B, Samaratunga H, Brooks DA. Sorvina A, et al. Among authors: moore c. Pathology. 2023 Oct;55(6):792-799. doi: 10.1016/j.pathol.2023.05.004. Epub 2023 Jun 20. Pathology. 2023. PMID: 37422404 Free article.
Altered endosomal-lysosomal biogenesis in melanoma.
Lam GT, Sorvina A, Martini C, Prabhakaran S, Ung BS, Lazniewska J, Moore CR, Beck AR, Hopkins AM, Johnson IRD, Caruso MC, Hickey SM, Brooks RD, Jackett L, Karageorgos L, Foster-Smith EJ, Malone V, Klebe S, O'Leary JJ, Brooks DA, Logan JM. Lam GT, et al. Among authors: moore cr. Neoplasia. 2023 Sep;43:100924. doi: 10.1016/j.neo.2023.100924. Epub 2023 Aug 9. Neoplasia. 2023. PMID: 37562257 Free PMC article.
Dynamic interplay between sortilin and syndecan-1 contributes to prostate cancer progression.
Lazniewska J, Li KL, Johnson IRD, Sorvina A, Logan JM, Martini C, Moore C, Ung BS, Karageorgos L, Hickey SM, Prabhakaran S, Heatlie JK, Brooks RD, Huzzell C, Warnock NI, Ward MP, Mohammed B, Tewari P, Martin C, O'Toole S, Edgerton LB, Bates M, Moretti P, Pitson SM, Selemidis S, Butler LM, O'Leary JJ, Brooks DA. Lazniewska J, et al. Among authors: moore c. Sci Rep. 2023 Aug 18;13(1):13489. doi: 10.1038/s41598-023-40347-7. Sci Rep. 2023. PMID: 37596305 Free PMC article.
Reinterpretation of prostate cancer pathology by Appl1, Sortilin and Syndecan-1 biomarkers.
Logan JM, Martini C, Sorvina A, Johnson IRD, Brooks RD, Caruso MC, Huzzell C, Moore CR, Karageorgos L, Butler LM, Tewari P, Prabhakaran S, Hickey SM, Klebe S, Samaratunga H, Delahunt B, Moretti K, O'Leary JJ, Brooks DA, Ung BS. Logan JM, et al. Among authors: moore cr. Sci Data. 2024 Aug 8;11(1):852. doi: 10.1038/s41597-024-03696-0. Sci Data. 2024. PMID: 39117701 Free PMC article.
Altered expression of vesicular trafficking machinery in prostate cancer affects lysosomal dynamics and provides insight into the underlying biology and disease progression.
Nturubika BD, Guardia CM, Gershlick DC, Logan JM, Martini C, Heatlie JK, Lazniewska J, Moore C, Lam GT, Li KL, Ung BS, Brooks RD, Hickey SM, Bert AG, Gregory PA, Butler LM, O'Leary JJ, Brooks DA, Johnson IRD. Nturubika BD, et al. Among authors: moore c. Br J Cancer. 2024 Nov;131(8):1263-1278. doi: 10.1038/s41416-024-02829-x. Epub 2024 Aug 31. Br J Cancer. 2024. PMID: 39217195 Free PMC article.
6,362 results